Segment Disclosures - Summary of Significant Expense Related To The Life Science Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Revenues	$ 16,146
Costs and operating expenses
Cost of revenues	475
Research and development
Total research and development expenses	58,747	$ 49,586
General and administrative
Total general and administrative expenses	25,420	32,610
Impairment of in-process research and development intangible asset	20,964	0
Total costs and operating expenses	105,606	82,196
Other segment income	9,965	8,406
Income tax benefit	(2,164)
Net loss	(77,331)	(73,790)
Reconciliation of profit or loss
Consolidated net loss	(77,331)	(73,790)
Operating Segments
Costs and operating expenses
Cost of revenues	475
Research and development
Total research and development expenses	58,747	49,586
General and administrative
Total general and administrative expenses	25,420	32,610
Impairment of in-process research and development intangible asset	20,964
Total costs and operating expenses	105,606	82,196
Other segment income	9,965	8,406
Income tax benefit	(2,164)
Net loss	(77,331)	(73,790)
Royalty revenues and sale of royalty rights | Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Revenues	16,146
Clinical product candidates | Operating Segments
Research and development
Total research and development expenses	24,456	10,638
Clinical product manufacturing | Operating Segments
Research and development
Total research and development expenses	11,200	3,333
Personnel-related expenses excluding stock-based compensation | Operating Segments
Research and development
Total research and development expenses	14,293	21,885
General and administrative
Total general and administrative expenses	5,837	8,553
Stock-based compensation
Research and development
Total research and development expenses	3,002	4,409
General and administrative
Total general and administrative expenses	9,943	12,537
Depreciation and amortization
Research and development
Total research and development expenses	1,922	1,634
Professional and consultant fees | Operating Segments
General and administrative
Total general and administrative expenses	4,491	6,347
Other | Operating Segments
Research and development
Total research and development expenses	3,874	7,687
General and administrative
Total general and administrative expenses	$ 5,149	$ 5,173